rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

NanoViricides, Inc.

NNVC · NYSE American

Health CareBiotechnologySetting up

NNVC stood above a rising 150-day average in 14 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 3.9% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 2
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
1
Institutions holding
49 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 14 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 0, Senate 1, executive 0; 1 people.

WhoDidAmountTraded
Kelly Loeffler Senate: U.S. Senate eFDSenatorsoldspouse$1k–$15k7 Apr 2020filed 1 May 2020

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders49+3 on the quarter
New · exited11 · 8
Reported value$3.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026919,313$1.3M+407,836+79.7%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026216,022$298K-9,359−4.2%
Connective Capital Management, LLCnew · filed 13 Aug 2026185,217$256K+185,217
BlackRock, Inc.added · filed 7 Aug 2026158,753$219K+10.0%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026131,923$182K+41,863+46.5%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026128,600$177K-6,300−4.7%
Miller Financial Services LLCadded · filed 29 Jul 2026112,000$155K+7,000+6.7%
UBS Group AGreduced · filed 13 Aug 202699,331$137K-114,028−53.4%
Creative Planningnew · filed 13 Aug 202686,761$120K+86,761
SUSQUEHANNA INTERNATIONAL GROUP, LLPreduced · filed 14 Aug 202660,616$84K-38,415−38.8%
31 Mar 2023 – 30 Jun 2026
243648Mar 23Dec 23Dec 24Sep 25Jun 26

News

Everyone who traded it

Anil Diwan Company insiderPresident · last 8 Aug 202210 · 81
Kelly Loeffler SenateSenator · last 7 Apr 20200 · 1
Milton Boniuk Company insider10% owner · last 21 May 201836 · 0
Eugene Seymour Company insiderChief Executive Officer · last 22 Sep 20151 · 0
Meeta Vyas Company insiderChief Financial Officer · last 25 Aug 20141 · 0
Theracour Pharma, Inc. Company insider10% owner · last 30 Jan 20130 · 88

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2026 · to 30 Jun 2026-95.7%
Share count trendFY 2026 · to 28 Sep 202610.9%
Cash and equivalentsFY 2026 · to 30 Jun 2026$2.8M
Free cash flowFY 2026 · to 30 Jun 2026−$7.8M

Analyst forecasts

No analyst forecasts yet.